Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 November 2024 | Story Leonie Bolleurs | Photo Supplied
SARIMA presentations 2024
The UFS DRD team that attended and presented at the 2024 SARIMA conference in Maputo, Mozambique.

The Directorate Research Development (DRD) team from the University of the Free State (UFS) joined research management professionals from across the globe at the 2024 Southern African Research and Innovation Management Association (SARIMA) Conference held in September this year. This year's conference, hosted for the first time in Mozambique, focused on the theme, It Takes a Village to Raise a Child, highlighting the collective effort needed in research and innovation.

The UFS delegation participated in workshops on navigating change, unlocking research impact potential, tools and techniques for research and innovation project management, reviewing research-related contracts, and assessing associated risks. The Bill and Melinda Gates Foundation also led a training session, while other workshops explored strengthening global research partnerships and advancing competencies in research management.

Opportunity to share and learn about best practices

Boemo Segoje, Officer for RIMS, Ethics and Creative Outputs, reflected on the conference’s collaborative atmosphere, noting the opportunity to share and learn about best practices. Segoje, alongside Maricel van Rooyen, Senior Officer: Project Manager, RIMS and Ethics, presented a poster titled, Empower the Village with an Effective Research Management System, showcasing the university’s InfoEd Research Information Management System (RIMS). “Our audience was particularly impressed with how RIMS consolidates various research functions into one platform,” said Segoje.

Another UFS poster by Mpho Mashamba, Officer: RIMS Development and Maintenance, and Ethics and Katleho Nyaile from the Centre for Graduate Support (CGS) focused on Breaking Down Silos: Enhancing Interdepartmental Communication in Research Administration. They highlighted the need for collaboration within the university, emphasising how interdepartmental communication enhances research outcomes. “We referred to the importance of collaborating with other units, keeping a line of communication open, as well as engaging various stakeholders. This is especially important for a team like ours whose work impacts every faculty member,” said Mashamba.

Mandy Jampies, Senior Officer Postdoctoral Fellows presented on It Takes a Village: Fostering Collaborative Networks for Postdoctoral Fellow Management. This talk focused on building a ‘village’ for postdoctoral fellows by streamlining visa processes and establishing partnerships with other institutions, such as the University of Johannesburg. "The audience showed great interest in our initiatives, particularly the visa partnership with the Department of Home Affairs," Jampies remarked.

Jampies’s commitment to supporting postdoctoral fellows extended beyond her presentation. In addition to discussing ways to build a supportive ‘village’ through streamlined visa processes and collaborative partnerships, she also played a role in the science communication pre-conference workshop. Reflecting on this workshop, Jampies noted it as a standout moment. “Boemo Segoje and I had the chance to present on the university’s initiatives to boost research visibility through newsletters, social media and webinars,” she shared.

Sugan Moodley, Director of Research Development Finance, remarked that it was interesting to see the Research Management progression made by universities and to compare similarities, differences, strengths and weaknesses between the UFS and other universities.

AI, here to stay

Mashamba found inspiration in a session by the University of Ghana, where he drew parallels between Ghana’s research fund and the UFS Central Research Fund. “Learning from their experience will help enhance our processes here at the university,” he shared. A big fan of lifelong learning, he saw the conference as a great opportunity to pick up new ideas. He said, "I really made the most of every moment. For me, a few key things stood out. First off, having clear policies and standard operating procedures (SOPs) is important for making things run smoothly and getting more done.”

He continued, “As for AI, it’s definitely here to stay. I’m excited about the potential AI has to help streamline our work. Once it’s ready to be used effectively in the workplace, I’d love to bring it into our systems and even use it to improve what we’re already doing." Additionally, Dr Glen Taylor, the Director of Research Development at the UFS, expressed similar enthusiasm for the AI presentation, finding it an interesting insight into the future of research processes.

For Segoje, the conference also highlighted the importance of leadership in research management, referring to a session by the University of Pretoria on Ubuntu leadership. “The emphasis on Ubuntu aligns with the UFS’s values, emphasising the importance of sharing knowledge and empowering others,” she said.

Reflecting on the conference, Jampies concluded, “SARIMA 2024 was one of the best conferences I have attended, providing a wealth of practical knowledge that I can apply to improve my work portfolio.”

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept